Goldman’s Vaccine Stocks May Prove Unhealthy for Your Portfolio
0
Goldman’s Vaccine Stocks May Prove Unhealthy for Your Portfolio CCN.com - News and Op-Eds for The Next Generation
Goldman Sachs is out with a list of non-tech stocks that may perform well on a Covid-19 vaccine. The problem? Most have already rallied.
Goldman’s Vaccine Stocks May Prove Unhealthy for Your Portfolio CCN.com - News and Op-Eds for The Next Generation